Rieger C, Schluchtermann J, Heidenreich J, Steenbock O, et al. Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in Germany. Eur J Cancer 2025;227:115621.
PMID: 40749416